Keywords

On this page readers can obtain a listing of documents classified by keywords. Click on the bookshelf icon of a keyword to obtain the concerned documents or to return to the main list of keywords.
All - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z
Expand the sub-collections menu.
67 documents on 1 page
 
 
 
Open this document and view its content

Building Clinical Trial Capacity to Develop a New Treatment for Multidrug-resistant Tuberculosis. (Bull World Health Organ 2016;94:147–152)

Year:

2016;

Pages:

6;


Regions:

 
Open this document and view its content

Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries

Year:

2007;

Pages:

4;

Regions:

 
Open this document and view its content

The Global Drug Facility as an intervention in the market for tuberculosis drugs (Bull World Health Organ 2015;93:237–248A)

Year:

2015;

Pages:

13;


Related documents:

Regions:

 
Open this document and view its content

Global Tuberculosis Report 2015. (20th edition)

Year:

2015;

Pages:

204;


Regions:

 
Open this document and view its content

Global Tuberculosis Report 2016

Year:

2016;

Pages:

214;


Related documents:

Regions:

 
Open this document and view its content

Global Tuberculosis Report 2017. Geneva: World Health Organization; 2017

Year:

2017;

Pages:

262;


Related documents:

Regions:

 
Open this document and view its content

Global Tuberculosis Report 2018. Geneva: World Health Organization; 2018

Year:

2018;

Pages:

243;


Related documents:

Regions:

 
Open this document and view its content

Global tuberculosis report 2019. Geneva: World Health Organization; 2019

Year:

2019;

Pages:

297;


Related documents:

Regions:

 
Open this document and view its content

Guidelines for Surveillance of Drug Resistance in Tuberculosis – 5th edition

Year:

2015;

Pages:

76;


Related documents:

Regions:

 
Open this document and view its content

Guidelines for TB infection Prevention and Control for Health Care workers in Kenya. July 2014

Year:

2014;

Pages:

89;


Countries:

 
Open this document and view its content

Guidelines for the Programmatic Management of Drug-resistant Tuberculosis. Emergency Update, 2008

Year:

2008;

Pages:

272;


Related documents:

Regions:

 
Open this document and view its content

Implementing Active Pharmacovigilance and Cohort Event Monitoring for Multidrug-Resistant Tuberculosis Regimens in the Philippines, April 2015

Year:

2015;

Pages:

67;


Related documents:

Countries:

 
Open this document and view its content

Infection tuberculeuse latente : lignes directrices unifiées et actualisées pour la prise en charge programmatique. Genève : Organisation mondiale de la Santé ; 2018. [English] [Russian]

Year:

2018;

Pages:

90;


Regions:

 
Open this document and view its content

Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization; 2018 [French] [Russian]

Year:

2018;

Pages:

78;


Regions:

 
Open this document and view its content

Multidrug-resistant tuberculosis in children and adolescents in the WHO European Region, Expert opinion. Copenhagen: WHO Regional Office for Europe; 2019

Year:

2019;

Pages:

49;


Related documents:

Regions:

 
Open this document and view its content

National Action Plan for Combating Multidrug-Resistant Tuberculosis. December 2015 (USA)

Year:

2015;

Pages:

38;


Related documents:

 
Open this document and view its content

National Guidelines on Management of Tuberculosis in Children Kenya. Second Edition, August 2013

Year:

2013;

Pages:

89;


Countries:

 
Open this document and view its content

The Need to Accelerate Access to New Drugs for Multidrug-resistant Tuberculosis. (Bull World Health Organ 2015;93:491–497)

Year:

2015;

Pages:

7;


Regions:

 
Open this document and view its content

Process of Implementing E-tb Manager, 2008–2016: A Summary of 10 Countries

Year:

2018;

Pages:

28;


Related documents:

Regions:

 
Open this document and view its content

Programmatic Management of Drug Resistant Tuberculosis (PMDT) - Kenya. Third Edition, June 2014

Year:

2014;

Pages:

106;


Countries:

 
Open this document and view its content

Reducing the Price of Treatment for Multidrug-resistant Tuberculosis Through the Global Drug Facility (Bull World Health Organ 2015;93:279–282)

Year:

2015;

Pages:

4;


Related documents:

Regions:

 
Open this document and view its content

Standard Operating Procedures. Active Pharmacovigilance Surveillance: Drug Safety Monitoring for New Medicines and Novel Regimens of the National TB Program in the Philippines

Year:

2015;

Pages:

21;


Countries:

 
Open this document and view its content

Technical Manual for Drug Susceptibility Testing of Medicines Used in the Treatment of Tuberculosis Geneva: World Health Organization; 2018

Year:

2018;

Pages:

52;


Related documents:

Regions:

 
Open this document and view its content

Tuberculosis surveillance and monitoring in Europe 2019 (2017 data). Copenhagen: WHO Regional Office for Europe; 2019. WHO Regional Office for Europe/European Centre for Disease Prevention and Control.

Year:

2019;

Pages:

164;


Related documents:

 
Open this document and view its content

WHO consolidated guidelines on drug-resistant tuberculosis treatment, Annexes 3–9. Geneva: World Health Organization; 2019

Year:

2019;

Pages:

76;


Related documents:

Regions:

 
Open this document and view its content

WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment. Geneva: World Health Organization; 2019

Year:

2019;

Pages:

104;


Related documents:

Regions:

 
Open this document and view its content

WHO Treatment Guidelines for Drug-resistant Tuberculosis. 2016 Update

Year:

2016;

Pages:

64;


Related documents:

Regions:

 
Open this document and view its content

Обновленное сводное руководство по программному ведению случаев латентной туберкулезной инфекции. Женева: Всемирная организация здравоохранения; 2018 (Russian version) Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization; 2018 [English] [French]

Year:

2018;

Pages:

84;


Related documents:

Regions:

 
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019